SCHEMBL3797526

SCHEMBL3797526

C(#Cc1cccc(C#Cc2ccccc2)c1C#Cc1ccccc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.60
▸ NPC1 O15118 4/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ CYP1A2 P05177 4/20 0.58
▸ CYP3A4 P08684 4/20 0.58
▸ CYP2C9 P11712 4/20 0.58
▸ CYP2C19 P33261 4/20 0.58
▸ MAPT P10636 3/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ HPGD P15428 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ KDM4E B2RXH2 3/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ RAB9A P51151 3/20 0.48
▸ CA12 O43570 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ KCNH2 Q12809 1/20 0.45
▸ DHFR P00374 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3792911 0.87 APP (0.63) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL9154580 0.85 NPC1 (0.48) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL5871989 0.84 APP (0.75) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL2114742 0.84 APP (0.75) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL6365224 0.83 FFAR1 (0.49) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL3786925 0.83 APP (0.57) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL5052289 0.81 APP (0.55) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL5141153 0.81 APP (0.55) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL3796509 0.81 APP (0.80) APPNPC1ALDH1A1CYP1A2CYP3A4
SCHEMBL30620385 0.81 ALDH1A1 (0.48) APPNPC1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210296120-A1 Method of filling high aspect ratio, small dimension gaps and formulations useful therein FOSTER KENNETH L (US) 2021-09-23 — — US claimed
US-7722851-B2 Bulk synthesis of carbon nanotubes from metallic and ethynyl compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2010-05-25 — — US claimed
EP-1585849-B1 BULK SYNTHESIS OF CARBON NANOTUBES FROM METALLIC AND ETHYNYL COMPOUNDS US GOV SEC NAVY (US) 2010-01-27 — — EP claimed
EP-1581578-B1 COMPOSITION AND METHOD TO ACHIEVE REDUCED THERMAL EXPANSION IN POLYARYLENE NETWORKS DOW GLOBAL TECHNOLOGIES INC (US) 2008-08-20 — — EP claimed
US-20080145300-A1 BULK SYNTHESIS OF CARBON NANOTUBES FROM METALLIC AND ETHYNYL COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2008-06-19 — — US claimed
US-20070227304-A1 SYNTHESIS OF METAL NANOPARTICLE COMPOSITIONS FROM METALLIC AND ETHYNYL COMPOUNDS THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY 2007-10-04 — — US claimed
US-7273509-B1 Synthesis of metal nanoparticle compositions from metallic and ethynyl compounds THE UNITED STATES OF AMERICA AS OF OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2007-09-25 — — US claimed
EP-1585849-A4 BULK SYNTHESIS OF CARBON NANOTUBES FROM METALLIC AND ETHYNYL COMPOUNDS US GOV SEC NAVY (US) 2007-03-14 — — EP claimed
US-20060024834-A1 Synthetic receptors for the detection of analytes NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-02-02 — — US claimed
EP-1585849-A1 BULK SYNTHESIS OF CARBON NANOTUBES FROM METALLIC AND ETHYNYL COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE NAVY (US) 2005-10-19 — — EP claimed
WO-2004095569-A1 METHOD OF FILLING HIGH ASPECT RATIO, SMALL DIMENSION GAPS AND FORMULATIONS USEFUL THEREIN DOW GLOBAL TECHNOLOGIES INC. (US) 2004-11-04 — — WO claimed
WO-2004011703-A1 BULK SYNTHESIS OF CARBON NANOTUBES FROM METALLIC AND ETHYNYL COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2004-02-05 — — WO claimed
WO-2004011178-A1 SYNTHESIS OF METAL NANOPARTICLE COMPOSITIONS FROM METALLIC AND ETHYNYL COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2004-02-05 — — WO claimed
US-20030108477-A1 Bulk synthesis of carbon nanotubes from metallic and ethynyl compounds NAVY, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2003-06-12 — — US claimed
US-20250161976-A1 NEW LOW-K MATERIALS DERIVED BY HYDROSILYLATION AND METHODS OF USING THEM FOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L’EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2025-05-22 — — US disclosed
US-11427656-B2 Photosensitive composition for hologram recording, hologram recording medium, and hologram SONY CORPORATION (JP) 2022-08-30 — — US disclosed
US-20210296120-A1 Method of filling high aspect ratio, small dimension gaps and formulations useful therein FOSTER KENNETH L (US) 2021-09-23 — — US disclosed
US-6359091-B1 AS DIELECTRICS IN SEMICONDUCTORS THE DOW CHEMICAL COMPANY 2002-03-19 — — US disclosed
US-5980853-A PYROLYZING AN AROMATIC ACETYLENIC MONOMERIC PRECURSOR OR A FORMED THERMOSETTING RESIN POLYMER TO FORM HIGH CHAR AMORPHOUS CARBON THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1999-11-09 — — US disclosed
US-5552505-A High temperature copolymers from inorganic-organic hybrid polymers and multi-ethynylbenzenes THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1996-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060024834-A1 Synthetic receptors for the detection of analytes FSHR, QRFPR, TACR1 APP 1726/4885NPC1 3575/4885ALDH1A1 915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback